Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.4087
-0.0003 (-0.07%)
At close: Aug 21, 2026, 4:00 PM EDT
0.4099
+0.0012 (0.29%)
After-hours: Aug 21, 2026, 4:00 PM EDT

Cellyan Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23
101312--
Market Cap Growth
-13.55%12.46%---
Enterprise Value
111314--
Last Close Price
0.410.571.08--

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23
PS Ratio
0.711.000.59--
PB Ratio
1.001.392.38--
P/TBV Ratio
1.011.412.43--
P/FCF Ratio
--23.79--
P/OCF Ratio
--20.87--

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23
EV/Sales Ratio
0.790.980.68--
EV/EBITDA Ratio
--52.12--
EV/EBIT Ratio
--72.87--
EV/FCF Ratio
--27.77--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23
Debt / Equity Ratio
0.130.130.480.491.18
Debt / EBITDA Ratio
--1.880.800.41
Debt / FCF Ratio
--4.76-0.43
Net Debt / Equity Ratio
0.110.11-0.130.350.28
Net Debt / EBITDA Ratio
-1.13-1.13-2.370.850.16
Net Debt / FCF Ratio
-1.32-1.32-1.26-3.280.10
Asset Turnover
1.211.212.252.76-
Inventory Turnover
26.1926.1923.9723.36-
Quick Ratio
1.691.692.651.370.88
Current Ratio
3.863.862.992.461.08
Return on Equity (ROE)
-15.59%-15.59%-0.58%54.96%-
Return on Assets (ROA)
-5.64%-5.64%1.31%17.28%-
Return on Invested Capital (ROIC)
-9.46%-13.42%-2.83%44.93%127.37%
Return on Capital Employed (ROCE)
-10.40%-10.40%2.90%30.40%114.30%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23
Earnings Yield
-11.83%-8.50%-0.23%--
FCF Yield
-8.19%-5.89%4.20%--
Buyback Yield / Dilution
-130.27%-130.27%-38.56%-7.64%-
SEC Filings: 10-K · 10-Q